Looking at last years Half Yearly report of Late February 2017, there was a comprehensive summary of the Cellmid operation and its constituent parts.
I look forward to this years HY in the coming weeks where there will no doubt be some excellent news.
Dont really expect to hear much in the interim but if the SP wants to go berserk in anticipation that fine with me.
- Forums
- ASX - By Stock
- AN1
- 2018 - The Year of the BioTechs
2018 - The Year of the BioTechs, page-9
-
-
- There are more pages in this discussion • 667 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
NEWS
Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
AN1 (ASX) Chart |
Day chart unavailable